SYNCRIP and cancer: Furthermore, the presence of SRSF4-RFP, SYNCRIP-GFP, and SNU13-GFP in extracellular vesicles was confirmed through flow cytometry analysis of CD9 positive extracellular vesicles from dying cancer cells (Supplementary Fig. 5E).